You searched for hypertension

News

Jesduvroq Approved for Anemia of CKD in Patients on Dialysis

February 2, 2023

Daprodustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.

News

Polypill Not Linked to Reduced Cognitive Decline in Seniors

January 31, 2023

But polypill with or without aspirin is associated with reduced functional decline for those aged 65 years or older with cardiovascular risk factors

News

AHA Presents Up-To-Date Statistics for Cardiovascular Disease

January 26, 2023

19.05 million deaths estimated for CVD globally in 2020, representing an increase of 18.71 percent from 2010

News

Intensive Blood Pressure Control May Delay Progression in Advanced CKD

January 25, 2023

Patients with advanced CKD have not been well-represented in trials evaluating intensive blood pressure control.

Drugs in the Pipeline

Intranasal Nalmefene Gets Priority Review for Opioid Overdose Treatment

January 20, 2023

OPNT003 is an intranasal formulation containing the high affinity opioid antagonist, nalmefene.

Drugs in the Pipeline

Obeticholic Acid Under Review for Pre-Cirrhotic Liver Fibrosis Due to NASH

January 19, 2023

The NDA is supported by two 2 positive interim analyses from the phase 3 REGENERATE trial that included patients with biopsy-proven stage 2 or 3 liver fibrosis due to NASH.

News

Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks

January 13, 2023

The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.

News

Comparable Adverse Effects Seen for HIF-PHIs and ESAs

January 12, 2023

Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.

Active Filters

Your search for hypertension returned 8 results

Sort Results:

Jesduvroq Approved for Anemia of CKD in Patients on Dialysis

Polypill Not Linked to Reduced Cognitive Decline in Seniors

AHA Presents Up-To-Date Statistics for Cardiovascular Disease

Intensive Blood Pressure Control May Delay Progression in Advanced CKD

Intranasal Nalmefene Gets Priority Review for Opioid Overdose Treatment

Obeticholic Acid Under Review for Pre-Cirrhotic Liver Fibrosis Due to NASH

Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks

Comparable Adverse Effects Seen for HIF-PHIs and ESAs